This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lynne Lamberg
JAMA contributor

JAMA. 1998;279:1595-1596.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

COSMETICS alleged to achieve druglike effects, such as the repair of sun damage and reversal of aging, add a new wrinkle to skin care, according to presentations at the annual meeting of the American Academy of Dermatology (AAD) in Orlando, Fla, in March, and interviews with government and industry experts. Debate continues on how well these products work, whether substances that behave like drugs should be marketed as cosmetics, and whether they are safe for long-term use.

These new cosmetics have been dubbed "cosmeceuticals," a term the Food and Drug Administration (FDA) does not recognize, John Bailey, PhD, director of the FDA's Office of Cosmetics and Colors, said in an interview. Cosmetics are defined by law as products not intended to affect the body's structure or functions, and drugs are defined as products that do so.

While several dermatologists noted in their presentations at the AAD meeting that . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?